BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35735268)

  • 1. Association of
    Wang N; Chen X; Hao Z; Yi H; Tang S
    Xenobiotica; 2022 May; 52(5):527-533. PubMed ID: 35735268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
    Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
    Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
    Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
    Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Yang Z; Xia Y; Chen D; Zhan S
    J Clin Pharm Ther; 2015 Apr; 40(2):186-91. PubMed ID: 25308608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
    Zhu J; Liu W; Zhang M; Lu L; Pan H; He X; Wang N; Yang M; Yi H; Tang S
    J Clin Pharm Ther; 2021 Oct; 46(5):1288-1294. PubMed ID: 34046917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Chen R; Wang J; Tang SW; Zhang Y; Lv XZ; Wu SS; Yang ZR; Xia YY; Chen DF; Zhan SY
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):812-8. PubMed ID: 27155186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
    Wang Y; Xiang X; Wu SQ; Chen G; Zhang MM; Wang MG; Wang FJ; Sandford AJ; He JQ
    Infect Genet Evol; 2017 Jul; 51():198-202. PubMed ID: 28389387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population.
    Pan H; Yang M; Lu L; Tao B; He X; Chen H; Yi H; Tang S
    Pharmacogenet Genomics; 2019 Jun; 29(4):84-90. PubMed ID: 30720667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
    Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
    J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
    Chen X; Hao Z; Pan H; Liu W; Lu L; Zhang M; He X; Yi H; Tang S
    Fundam Clin Pharmacol; 2023 Aug; 37(4):858-867. PubMed ID: 36855016
    [TBL] [Abstract][Full Text] [Related]  

  • 12.  NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.
    Lv X; Tang S; Xia Y; Zhang Y; Wu S; Yang Z; Li X; Tu D; Chen Y; Deng P; Ma Y; Chen D; Chen R; Zhan S
    Ann Hepatol; 2012; 11(5):700-7. PubMed ID: 22947533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Chen R; Wang J; Tang S; Zhang Y; Lv X; Wu S; Xia Y; Deng P; Ma Y; Tu D; Chen D; Zhan S
    Tuberculosis (Edinb); 2015 Jan; 95(1):68-74. PubMed ID: 25498879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
    Ji GY; Wang Y; Wu SQ; Liu QQ; Wu JC; Zhang MM; Sandford AJ; He JQ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.
    Yang M; Qiu Y; Jin Y; Liu W; Wang Q; Yi H; Tang S
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00696. PubMed ID: 33300686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study.
    Chbili C; Fathallah N; Laadhari C; Ouni B; Saguem S; Ben Fredj M; Abdelghani A; Ben Saad H; Ben Salem C
    Gene; 2022 Jan; 809():146019. PubMed ID: 34656741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen type XVIII alpha 1 chain (COL18A1) variants affect the risk of anti-tuberculosis drug-induced hepatotoxicity: A prospective study.
    Cheng Y; Jiao L; Li W; Wang J; Lin Z; Lai H; Ying B
    J Clin Lab Anal; 2021 Feb; 35(2):e23630. PubMed ID: 33296124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
    Wang N; Guo S; Liu H; Ding Y; Yao R; Liu Z; Zhu H; Chen X; Yang X; Chen X; Lu Y
    Xenobiotica; 2022 May; 52(5):520-526. PubMed ID: 35723590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Xia Y; Gao P; Tu D; Chen D; Zhan S
    PLoS One; 2015; 10(3):e0118862. PubMed ID: 25789467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms of Delta-Like 1 Homolog Influence the Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity.
    Fu Y; Liu T; Song J; Jiao L; Zhou J; Bai H; Zhao Z; Chen H; Wu T; Lyv M; Zhou Y; Ying B; Xu Y
    DNA Cell Biol; 2021 Feb; 40(2):231-238. PubMed ID: 33297832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.